Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit

Journal of the Neurological Sciences
L E RosengrenO Andersen

Abstract

Glial fibrillary acidic protein (GFAp) was analysed in cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and healthy controls. Patients with relapsing-remitting course (n = 13) were followed with quantitative neurological examinations and lumbar punctures during a 24-month period. The patient group was a subsample from a randomised, double-blind clinical trial of acyclovir on MS: 7 patients were treated with acyclovir and 6 were placebo controls. CSF was also collected from 5 age-matched healthy individuals with normal quantitative neurological examinations. The CSF assays disclosed increased concentrations of GFAp in MS patients compared to controls (p < 0.01). Furthermore, the GFAp levels correlated significantly with the deficit score (p < 0.01) but not with exacerbation frequency. When the group treated with acyclovir was compared with the placebo group, no significant change of CSF GFAp was observed. In the present study we show that GFAp is increased in CSF of patients with MS and that the levels correlate with the neurological dysfunction. Further work is needed to ascertain whether determinations of CSF GFAp can be used to monitor disease progression in MS or whether the assay may be useful to evaluate ...Continue Reading

References

Sep 1, 1992·Journal of Neuroscience Methods·L E RosengrenA Hamberger
May 7, 1971·Brain Research·L F EngB Gerstl
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Mar 1, 1994·Journal of Neuroscience Methods·L E RosengrenL Hagberg
Feb 1, 1993·Brain : a Journal of Neurology·B Runmarker, O Andersen

❮ Previous
Next ❯

Citations

Jun 23, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Hideki NagashimaRyota Teshima
May 22, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Hideki NagashimaRyota Teshima
Mar 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Roberto MadedduAndrea Montella
Jan 12, 2012·Bulletin of Experimental Biology and Medicine·N V LyubimovaN E Kushlinskii
Apr 22, 2004·Journal of Immunological Methods·A PetzoldE J Thompson
May 2, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Vladimir P ChekhoninTatiana B Dmitriyeva
May 30, 2008·The Tohoku Journal of Experimental Medicine·Rina TakanoYasuto Itoyama
Apr 4, 2013·Biomarkers in Medicine·Aysegül Ilhan-MutluMatthias Preusser
Mar 4, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L DotevallL E Rosengren
Jun 27, 1998·Molecular and Chemical Neuropathology·Y NagataM Honda
Mar 6, 2016·Journal of Neuroimmunology·Joachim BurmanClas Malmeström
Sep 24, 2015·Expert Review of Molecular Diagnostics·Mehdi TouatAhmed Idbaih
Jul 6, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·William J HousleyDavid A Hafler
Jan 7, 2004·Acta Neurologica Scandinavica·S HaghighiL Rosengren
Feb 1, 2011·Annals of Neurology·Martin GunnarssonJan Lycke
Feb 28, 2014·Acta Neurologica Scandinavica·J BurmanJ Fagius
Nov 26, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Felix BenningerIsrael Steiner
Nov 8, 2007·Acta Neurologica Scandinavica·T BrommelandV Isaksen
Apr 17, 2016·Progress in Neurobiology·Pejman Rahimian, Johnny J He
Jul 4, 2012·Cytokine·Ana Karolina de Santana NunesChristina Alves Peixoto
May 12, 2009·Neurobiology of Disease·Hayrettin TumaniUNKNOWN BioMS Study Group
Feb 22, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Therese RosenlingRainer Bischoff
Sep 29, 2009·Journal of Neuroimmunology·Amer AwadOlaf Stuve
May 25, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Markus AxelssonAnders Svenningsson
Apr 27, 2017·Einstein·Renan Barros DominguesCarlos Augusto Senne Soares
Oct 8, 1998·Multiple Sclerosis : Clinical and Laboratory Research·G GiovannoniE J Thompson
Nov 2, 2017·Expert Review of Clinical Immunology·Jan Lycke, Henrik Zetterberg
Oct 19, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Christian BarroJens Kuhle
Dec 21, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Heidi HögelLaura Airas
Mar 4, 2018·Cold Spring Harbor Perspectives in Medicine·Anu PaulRoopali Gandhi
Jul 5, 2008·Expert Review of Molecular Diagnostics·Hayrettin TumaniJohannes Brettschneider
Jan 23, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Tanuja Chitnis, Alexandre Prat
Oct 6, 2018·Scientific Reports·A AbdelhakM Otto
May 26, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Nicolas DubuissonSharmilee Gnanapavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.